Single Nucleotide Polymorphism (SNP) Genotyping Market

Table of Content

SECTION I: REPORT OVERVIEW

1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions

2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis

2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources

2.4.2. Primary Research
2.4.2.1. Introduction

2.4.2.2. Types
2.4.2.2.1. Qualitative
2.4.2.2.2. Quantitative

2.4.2.3. Advantages

2.4.2.4. Techniques
2.4.2.4.1. Interviews
2.4.2.4.2. Surveys
2.4.2.4.3. Focus Groups
2.4.2.4.4. Observational Research
2.4.2.4.5. Social Media Interactions

2.4.2.5. Stakeholders
2.4.2.5.1. Company Executives (CXOs)
2.4.2.5.2. Board of Directors
2.4.2.5.3. Company Presidents and Vice Presidents
2.4.2.5.4. Key Opinion Leaders
2.4.2.5.5. Research and Development Heads
2.4.2.5.6. Technical Experts
2.4.2.5.7. Subject Matter Experts
2.4.2.5.8. Scientists
2.4.2.5.9. Doctors and Other Healthcare Providers

2.4.2.6. Ethics and Integrity
2.4.2.6.1. Research Ethics
2.4.2.6.2. Data Integrity

2.4.3. Analytical Tools and Databases

3. MARKET DYNAMICS
3.1. Forecast Methodology
3.1.1. Top-Down Approach
3.1.2. Bottom-Up Approach
3.1.3. Hybrid Approach

3.2. Market Assessment Framework
3.2.1. Total Addressable Market (TAM)
3.2.2. Serviceable Addressable Market (SAM)
3.2.3. Serviceable Obtainable Market (SOM)
3.2.4. Currently Acquired Market (CAM)

3.3. Forecasting Tools and Techniques
3.3.1. Qualitative Forecasting
3.3.2. Correlation
3.3.3. Regression
3.3.4. Time Series Analysis
3.3.5. Extrapolation
3.3.6. Convergence
3.3.7. Forecast Error Analysis
3.3.8. Data Visualization
3.3.9. Scenario Planning
3.3.10. Sensitivity Analysis

3.4. Key Considerations
3.4.1. Demographics
3.4.2. Market Access
3.4.3. Reimbursement Scenarios
3.4.4. Industry Consolidation

3.5. Robust Quality Control
3.6. Key Market Segmentations
3.7. Limitations

4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates

4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry

4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk

4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market

4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution

4.2.6. Interest Rates
4.2.6.1. Overview of Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk

4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation

4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario

4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War

4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies

4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. R&D Innovation
4.2.11.7. Stock Market Performance
4.2.11.8. Supply Chain
4.2.11.9. Cross-Border Dynamics

SECTION II: QUALITATIVE INSIGHTS

5. EXECUTIVE SUMMARY

6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of Single Nucleotide Polymorphism (SNP) Genotyping
6.2.1. Key Characteristics of Single Nucleotide Polymorphism (SNP) Genotyping
6.2.2. Key Applications of the Single Nucleotide Polymorphism (SNP) Genotyping
6.2.3. Challenges Associated with Single Nucleotide Polymorphism (SNP) Genotyping

6.3. Future Perspective

7. REGULATORY SCENARIO

SECTION III: MARKET OVERVIEW

8. COMPREHENSIVE DATABASE OF LEADING PLAYERS

9. COMPETITIVE LANDSCAPE
9.1. Chapter Overview
9.2. Single Nucleotide Polymorphism (SNP) Genotyping: Overall Market Landscape
9.2.1. Analysis by Year of Establishment
9.2.2. Analysis by Company Size
9.2.3. Analysis by Location of Headquarters

9.2.4. Single Nucleotide Polymorphism (SNP) Genotyping: Overall Market Landscape
9.2.4.1. Analysis by Technology Type
9.2.4.2. Analysis by Product Type
9.2.4.3. Analysis by Application Type

10. PORTER'S FIVE FORCES ANALYSIS

11. COMPETITIVE COMPETITIVENESS ANALYSIS

12. STARTUP ECOSYSTEM IN THE SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET
12.1. Single Nucleotide Polymorphism (SNP) Genotyping: Market Landscape of Startups
12.1.1. Analysis by Year of Establishment
12.1.2. Analysis by Company Size
12.1.3. Analysis by Company Size and Year of Establishment
12.1.4. Analysis by Location of Headquarters
12.1.5. Analysis by Company Size and Location of Headquarters
12.1.6. Analysis by Ownership Structure

12.2. Key Findings

SECTION IV: COMPANY PROFILES

13. COMPANY PROFILES
13.1. Chapter Overview
13.2. 10x Genomics
13.2.1. Company Overview
13.2.2. Company Mission
13.2.3. Company Footprint
13.2.4. Management Team
13.2.5. Contact Details
13.2.6. Financial Performance
13.2.7. Operating Business Segments
13.2.8. Product Portfolio
13.2.9. MOAT Analysis
13.2.10. Recent Developments and Future Outlook

* similar detail is presented for other below mentioned companies based on information in the public domain

13.3. Agilent Technologies
13.4. Agena Bioscience
13.5. Bio-Rad Laboratories
13.6. BGI
13.7. Douglas Scientific
13.8. Fluidigm
13.9. Illumina
13.10. Novogene
13.11. Oxford Nanopore Technologies
13.12. Pacific Biosciences
13.13. QIAGEN
13.14. ROCHE
13.15. Thermo Fisher Scientific

SECTION V: MARKET TRENDS

14. RECENT DEVELOPMENTS
14.1. Chapter Overview
14.2. Recent Funding
14.3. Recent Partnerships
14.4. Other Recent Initiatives

SECTION VI: MARKET OPPORTUNITY ANALYSIS

15. GLOBAL SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Trends Disruption Impacting Market
15.4. Demand Side Trends
15.5. Supply Side Trends
15.6. Global Single Nucleotide Polymorphism (SNP) Genotyping Market, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

15.7. Multivariate Scenario Analysis
15.7.1. Conservative Scenario
15.7.2. Optimistic Scenario

15.8. Investment Feasibility Index
15.9. Key Market Segmentations

16. MARKET OPPORTUNITIES BASED ON TYPE OF TECHNOLOGY
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Revenue Shift Analysis
16.4. Market Movement Analysis
16.5. Penetration-Growth (P-G) Matrix
16.6. Single Nucleotide Polymorphism (SNP) Genotyping Market for Polymerase Chain Reaction: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.7. Single Nucleotide Polymorphism (SNP) Genotyping Market for Next Generation Sequencing: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.8. Single Nucleotide Polymorphism (SNP) Genotyping Market for Microarrays and GeneChips: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.9. Single Nucleotide Polymorphism (SNP) Genotyping Market for Taqman Allelic Discrimination: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.10. Single Nucleotide Polymorphism (SNP) Genotyping Market for SNP Pyrosequencing: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.11. Single Nucleotide Polymorphism (SNP) Genotyping Market for SNPIex Genotyping System: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.12. Single Nucleotide Polymorphism (SNP) Genotyping Market for Sequemon MassArray Maldi-TOF: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.13. Single Nucleotide Polymorphism (SNP) Genotyping Market for Other Technologies: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

16.14. Data Triangulation and Validation
16.14.1. Secondary Sources
16.14.2. Primary Sources
16.14.3. Statistical Modeling

17. MARKET OPPORTUNITIES BASED ON TYPE OF PRODUCT
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Revenue Shift Analysis
17.4. Market Movement Analysis
17.5. Penetration-Growth (P-G) Matrix
17.6. Single Nucleotide Polymorphism (SNP) Genotyping Market for Consumables: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.7. Single Nucleotide Polymorphism (SNP) Genotyping Market for Instruments: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
17.8. Single Nucleotide Polymorphism (SNP) Genotyping Market for Services: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

17.9. Data Triangulation and Validation
17.9.1. Secondary Sources
17.9.2. Primary Sources
17.9.3. Statistical Modeling

18. MARKET OPPORTUNITIES BASED ON TYPE OF APPLICATION
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Revenue Shift Analysis
18.4. Market Movement Analysis
18.5. Penetration-Growth (P-G) Matrix
18.6. Single Nucleotide Polymorphism (SNP) Genotyping Market for Diagnostic Research: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.7. Single Nucleotide Polymorphism (SNP) Genotyping Market for Pharmcogenomics: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.8. Single Nucleotide Polymorphism (SNP) Genotyping Market for Agriculture Biotechnology: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.9. Single Nucleotide Polymorphism (SNP) Genotyping Market for Breeding: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
18.10. Single Nucleotide Polymorphism (SNP) Genotyping Market for Animal Livestock: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

18.11. Data Triangulation and Validation
18.11.1. Secondary Sources
18.11.2. Primary Sources
18.11.3. Statistical Modeling

19. MARKET OPPORTUNITIES FOR SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING IN NORTH AMERICA
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Revenue Shift Analysis
19.4. Market Movement Analysis
19.5. Penetration-Growth (P-G) Matrix

19.6. Single Nucleotide Polymorphism (SNP) Genotyping Market in North America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.6.1. Single Nucleotide Polymorphism (SNP) Genotyping Market in the US: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.6.2. Single Nucleotide Polymorphism (SNP) Genotyping Market in Canada: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
19.6.3. Single Nucleotide Polymorphism (SNP) Genotyping Market in Mexico: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

19.7. Data Triangulation and Validation

20. MARKET OPPORTUNITIES FOR SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING IN EUROPE
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Revenue Shift Analysis
20.4. Market Movement Analysis
20.5. Penetration-Growth (P-G) Matrix

20.6. Single Nucleotide Polymorphism (SNP) Genotyping Market in Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.6.1. Single Nucleotide Polymorphism (SNP) Genotyping Market in France: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.6.2. Single Nucleotide Polymorphism (SNP) Genotyping Market in Germany: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.6.3. Single Nucleotide Polymorphism (SNP) Genotyping Market in Italy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.6.4. Single Nucleotide Polymorphism (SNP) Genotyping Market in Spain: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.6.5. Single Nucleotide Polymorphism (SNP) Genotyping Market in the UK: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
20.6.6. Single Nucleotide Polymorphism (SNP) Genotyping Market in Rest of the Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

20.7. Data Triangulation and Validation

21. MARKET OPPORTUNITIES FOR SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING IN ASIA-PACIFIC
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Revenue Shift Analysis
21.4. Market Movement Analysis
21.5. Penetration-Growth (P-G) Matrix

21.6. Single Nucleotide Polymorphism (SNP) Genotyping Market in Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.1. Single Nucleotide Polymorphism (SNP) Genotyping Market in China: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.2. Single Nucleotide Polymorphism (SNP) Genotyping Market in Japan: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.3. Single Nucleotide Polymorphism (SNP) Genotyping Market in India: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.4. Single Nucleotide Polymorphism (SNP) Genotyping Market in South Korea: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.5. Single Nucleotide Polymorphism (SNP) Genotyping Market in Australia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.6. Single Nucleotide Polymorphism (SNP) Genotyping Market in Russia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.7. Single Nucleotide Polymorphism (SNP) Genotyping Market in Thailand: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.8. Single Nucleotide Polymorphism (SNP) Genotyping Market in Malaysia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.9. Single Nucleotide Polymorphism (SNP) Genotyping Market in Indonesia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
21.6.10. Single Nucleotide Polymorphism (SNP) Genotyping Market in Rest of the Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

21.7. Data Triangulation and Validation

22. MARKET OPPORTUNITIES FOR SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING IN MIDDLE EAST AND NORTH AFRICA (MENA)
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Revenue Shift Analysis
22.4. Market Movement Analysis
22.5. Penetration-Growth (P-G) Matrix

22.6. Single Nucleotide Polymorphism (SNP) Genotyping Market in Middle East and North Africa (MENA): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.1. Single Nucleotide Polymorphism (SNP) Genotyping Market in Iran: Historical Trends (Since 2020) and Forecasted Estimates (Till 205)
22.6.2. Single Nucleotide Polymorphism (SNP) Genotyping Market in Saudi Arabia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
22.6.3. Single Nucleotide Polymorphism (SNP) Genotyping Market in Egypt: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

22.7. Data Triangulation and Validation

23. MARKET OPPORTUNITIES FOR SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING IN LATIN AMERICA
23.1. Chapter Overview
23.2. Key Assumptions and Methodology
23.3. Revenue Shift Analysis
23.4. Market Movement Analysis
23.5. Penetration-Growth (P-G) Matrix

23.6. Single Nucleotide Polymorphism (SNP) Genotyping Market in Latin America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.1. Single Nucleotide Polymorphism (SNP) Genotyping Market in Brazil: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.2. Single Nucleotide Polymorphism (SNP) Genotyping Market in Argentina: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
23.6.3. Single Nucleotide Polymorphism (SNP) Genotyping Market in Rest of Latin America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

23.7. Data Triangulation and Validation

24. ADJACENT MARKET ANALYSIS

SECTION VII: STRATEGIC TOOLS

25. KEY WINNING STRATEGIES

26. VALUE CHAIN ANALYSIS

27. ROOTS STRATEGIC RECOMMENDATIONS

SECTION VIII: OTHER EXCLUSIVE INSIGHTS

28. INSIGHTS FROM PRIMARY RESEARCH

29. REPORT CONCLUSION

SECTION IX: APPENDIX

30. TABULATED DATA

31. LIST OF COMPANIES AND ORGANIZATIONS

32. CUSTOMIZATION OPPORTUNITIES

33. ROOTS SUBSCRIPTION SERVICES

34. AUTHOR DETAILS